JM

John A. McCauley

Merck: 52 patents #96 of 9,382Top 2%
MC Msd R&D (China) Co.: 3 patents #13 of 80Top 20%
MS Msd Italia S.R.L.: 2 patents #2 of 58Top 4%
WR Walter And Eliza Hall Institute Of Medical Research: 2 patents #59 of 228Top 30%
UP University of Pennsylvania: 1 patents #1,260 of 2,719Top 50%
📍 Maple Glen, PA: #2 of 8 inventorsTop 25%
🗺 Pennsylvania: #687 of 74,527 inventorsTop 1%
Overall (All Time): #53,880 of 4,157,543Top 2%
50
Patents All Time

Issued Patents All Time

Showing 26–50 of 50 patents

Patent #TitleCo-InventorsDate
9233977 Leucine-rich repeat kinase enzyme activity Hemaka A. Rajapakse, Thomas J. Greshock, John M. Sanders, Boyoung Kim, Vanessa L. Rada +3 more 2016-01-12
9090661 Inhibitors of hepatitis C virus replication Craig A. Coburn, Steven W. Ludmerer, Kun Liu, Joseph P. Vacca, Hao Wu +9 more 2015-07-28
8927569 Macrocyclic compounds as antiviral agents Steven Harper, Vincenzo Summa, Nigel J. Liverton, John W. Butcher, Marcello Di Filippo +4 more 2015-01-06
8828930 Hepatitis C virus NS3 protease inhibitors Nigel J. Liverton, Michael T. Rudd 2014-09-09
8591878 Therapeutic compounds Nigel J. Liverton, Steven Harper, Charles J. McIntyre, Michael T. Rudd 2013-11-26
8461107 HCV NS3 protease inhibitors Nigel J. Liverton, John W. Butcher, Kevin F. Gilbert, Charles J. McIntyre, Michael T. Rudd 2013-06-11
8377874 HCV NS3 protease inhibitors Nigel J. Liverton, Joseph P. Vacca, Michael T. Rudd 2013-02-19
8309540 HCV NS3 protease inhibitors Nigel J. Liverton, Joseph P. Vacca, Joseph J. Romano, Michael T. Rudd 2012-11-13
8278322 HCV NS3 protease inhibitors M. Katharine Holloway, Nigel J. Liverton, Michael T. Rudd, Joseph P. Vacca, Steven W. Ludmerer +1 more 2012-10-02
8216999 HCV NS3 protease inhibitors M. Katharine Holloway, Nigel J. Liverton, Steven W. Ludmerer, David B. Olsen, Michael T. Rudd +2 more 2012-07-10
8080654 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors Steven Harper, Vincenzo Summa, Nigel J. Liverton 2011-12-20
7973040 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors Steven Harper, Vincenzo Summa, Nigel J. Liverton 2011-07-05
7879797 HCV NS3 protease inhibitors M. Katharine Holloway, Nigel J. Liverton, Steven W. Ludmerer, David B. Olsen, Michael T. Rudd +1 more 2011-02-01
7592360 3-fluoro-piperidines as NMDA/NR2B antagonists Nigel J. Liverton, Christopher F. Claiborne, David A. Claremon 2009-09-22
7470664 HCV NS3 protease inhibitors M. Katharine Holloway, Nigel J. Liverton, Steven W. Ludmerer, David B. Olsen, Michael T. Rudd +2 more 2008-12-30
7452893 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists Wayne Thompson, Steven D. Young, Brian Phillips, Peter M. Munson, Willie Whitter +6 more 2008-11-18
7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists Nigel J. Liverton, John W. Butcher, Charles J. McIntyre, Christopher F. Claiborne, David A. Claremon +3 more 2007-08-21
7217716 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Christopher F. Claiborne, David A. Claremon, Brian Libby, John W. Butcher, Nigel J. Liverton +4 more 2007-05-15
7053089 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Christopher F. Claiborne, John W. Butcher, David A. Claremon, Brian Libby, Nigel J. Liverton +4 more 2006-05-30
6495561 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists Wayne Thompson, David A. Claremon, Peter M. Munson 2002-12-17
6440976 Iminopyrimidine NMDA NR2B receptor antagonists David A. Claremon, Nigel J. Liverton, Cory R. Theberge 2002-08-27
6380205 2-cyclohexyl quinazoline NMDA/NR2B antagonists Wayne Thompson, David A. Claremon, Peter M. Munson 2002-04-30
6316474 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists Cory R. Theberge, Nigel J. Liverton, David A. Claremon, Christopher F. Claiborne 2001-11-13
6291499 2-cyclohexyl benzimidazole NMDA/NR2B antagonists Wayne Thompson, David A. Claremon, Peter M. Munson 2001-09-18
5621108 Processes and intermediates for preparing macrocycles Amos B. Smith, III, Stephen M. Condon, Johnnie L. Leazer, Jr., Robert E. Maleczka, James William Leahy 1997-04-15